- Home
- ALEC vs ACU Comparison
ALEC vs ACU Comparison
Compare ALEC & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- ACU
- Stock Information
- Founded
- ALEC 2013
- ACU 1867
- Country
- ALEC United States
- ACU United States
- Employees
- ALEC N/A
- ACU N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- ACU Industrial Machinery/Components
- Sector
- ALEC Health Care
- ACU Consumer Discretionary
- Exchange
- ALEC Nasdaq
- ACU Nasdaq
- Market Cap
- ALEC 162.6M
- ACU 141.5M
- IPO Year
- ALEC 2019
- ACU N/A
- Fundamental
- Price
- ALEC $1.18
- ACU $40.15
- Analyst Decision
- ALEC Buy
- ACU
- Analyst Count
- ALEC 7
- ACU 0
- Target Price
- ALEC $4.10
- ACU N/A
- AVG Volume (30 Days)
- ALEC 528.1K
- ACU 8.8K
- Earning Date
- ALEC 05-07-2025
- ACU 04-21-2025
- Dividend Yield
- ALEC N/A
- ACU 1.48%
- EPS Growth
- ALEC N/A
- ACU N/A
- EPS
- ALEC N/A
- ACU 2.45
- Revenue
- ALEC $100,558,000.00
- ACU $194,489,991.00
- Revenue This Year
- ALEC N/A
- ACU $4.87
- Revenue Next Year
- ALEC $40.79
- ACU $3.65
- P/E Ratio
- ALEC N/A
- ACU $16.50
- Revenue Growth
- ALEC 3.60
- ACU 1.56
- 52 Week Low
- ALEC $1.13
- ACU $32.85
- 52 Week High
- ALEC $6.78
- ACU $50.00
- Technical
- Relative Strength Index (RSI)
- ALEC 35.06
- ACU 56.43
- Support Level
- ALEC $1.26
- ACU $38.30
- Resistance Level
- ALEC $1.36
- ACU $40.95
- Average True Range (ATR)
- ALEC 0.08
- ACU 1.13
- MACD
- ALEC -0.00
- ACU -0.04
- Stochastic Oscillator
- ALEC 18.92
- ACU 57.81
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About ACU Acme United Corporation.
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.